0001140361-18-009548.txt : 20180222 0001140361-18-009548.hdr.sgml : 20180222 20180222131057 ACCESSION NUMBER: 0001140361-18-009548 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180216 FILED AS OF DATE: 20180222 DATE AS OF CHANGE: 20180222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VandenEnden Koert CENTRAL INDEX KEY: 0001732118 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34949 FILM NUMBER: 18631913 MAIL ADDRESS: STREET 1: C/O ARBUTUS BIOPHARMA CORP. STREET 2: SUITE 100, 8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arbutus Biopharma Corp CENTRAL INDEX KEY: 0001447028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980597776 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 BUSINESS PHONE: 604-419-3200 MAIL ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp DATE OF NAME CHANGE: 20110607 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20081003 3 1 doc1.xml FORM 3 X0206 3 2018-02-16 0 0001447028 Arbutus Biopharma Corp ABUS 0001732118 VandenEnden Koert C/O ARBUTUS BIOPHARMA CORPORATION SUITE 100, 8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 BRITISH COLUMBIA, CANADA 0 1 0 0 Interim CFO Common Shares 2750 D Stock Options (Right to Buy) 3.05 2016-12-07 2026-10-03 Common Shares 35000 D Stock Options (Right to Buy) 3.15 2017-03-24 2027-03-24 Common Shares 15000 D Grant date is reflected above. The options vest as follows: 1/3 on 10/3/2017; 1/3 on 10/3/2018 and 1/3 on 10/3/2019. Grant date is reflected above. The options vest as follows: 1/3 on 3/24/2018; 1/3 on 3/24/2019; and 1/3 on 3/24/2020. /s/ Koert VandenEnden 2018-02-20